Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The term **A + fish oil** is a non-specific designation that typically refers to a combination of Vitamin A (retinol or its derivatives) and fish oil, which is a source of omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). This combination is most frequently encountered in the context of dietary supplements, particularly cod liver oil, which naturally contains high concentrations of both Vitamin A and omega-3 fatty acids. Vitamin A is essential for vision, immune function, and cellular communication, while fish oil is utilized for its cardiovascular benefits and anti-inflammatory properties. Alternatively, in certain clinical research contexts, 'A' may serve as a shorthand for aspirin (acetylsalicylic acid), and the combination is studied for its synergistic effects on inflammatory resolution through the production of aspirin-triggered resolvins. However, 'A' is not a recognized canonical name, sponsor development code, or brand name for a specific pharmaceutical agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on A + fish oil.